These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19585679)

  • 1. [Mutations of IDH1 and 2 genes: a molecular diagnosis of low-grade gliomas].
    Larsen CJ
    Bull Cancer; 2009 Jun; 96(6):641-2. PubMed ID: 19585679
    [No Abstract]   [Full Text] [Related]  

  • 2. IDH mutations in human glioma.
    Kim W; Liau LM
    Neurosurg Clin N Am; 2012 Jul; 23(3):471-80. PubMed ID: 22748659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into glioma classification based on isocitrate dehydrogenase 1 and 2 gene status.
    Shibahara I; Sonoda Y; Kanamori M; Saito R; Kumabe T; Tominaga T
    Brain Tumor Pathol; 2011 Jul; 28(3):203-8. PubMed ID: 21735252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review.
    Hodges TR; Choi BD; Bigner DD; Yan H; Sampson JH
    J Neurosurg; 2013 Jun; 118(6):1176-80. PubMed ID: 23581583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IDH1/2 mutations in gliomas].
    Nobusawa S; Yokoo H
    Brain Nerve; 2011 Dec; 63(12):1378-86. PubMed ID: 22147457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.
    Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
    Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas.
    Shibahara I; Sonoda Y; Kanamori M; Saito R; Yamashita Y; Kumabe T; Watanabe M; Suzuki H; Kato S; Ishioka C; Tominaga T
    Int J Clin Oncol; 2012 Dec; 17(6):551-61. PubMed ID: 21971842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma-derived mutations in IDH: from mechanism to potential therapy.
    Fu Y; Huang R; Du J; Yang R; An N; Liang A
    Biochem Biophys Res Commun; 2010 Jun; 397(2):127-30. PubMed ID: 20510884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What do we know about IDH1/2 mutations so far, and how do we use it?
    Horbinski C
    Acta Neuropathol; 2013 May; 125(5):621-36. PubMed ID: 23512379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
    Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ
    Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas.
    Weller M; Wick W; von Deimling A
    Glia; 2011 Aug; 59(8):1200-4. PubMed ID: 21294161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line.
    Luchman HA; Chesnelong C; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Aug; 15(8):979-80. PubMed ID: 23757293
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffuse glioma - Rare homozygous IDH point mutation, is it an oncogenetic mechanism?
    Singh A; Gurav M; Dhanavade S; Shetty O; Epari S
    Neuropathology; 2017 Dec; 37(6):582-585. PubMed ID: 28782849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sensitive intraoperative detection of mutations in the isocitrate dehydrogenase 1 and 2 genes during surgery for glioma.
    Kanamori M; Kikuchi A; Watanabe M; Shibahara I; Saito R; Yamashita Y; Sonoda Y; Kumabe T; Kure S; Tominaga T
    J Neurosurg; 2014 Jun; 120(6):1288-97. PubMed ID: 24745708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
    Kloosterhof NK; Bralten LB; Dubbink HJ; French PJ; van den Bent MJ
    Lancet Oncol; 2011 Jan; 12(1):83-91. PubMed ID: 20615753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yet another utility for isocitrate dehydrogenase.1: Can it serve as an immunomarker to assess tumor margins in gliomas?
    Rao S; Rajkumar A; Sundaram S; Joyce ME; Duvuru P
    J Cancer Res Ther; 2020; 16(6):1476-1481. PubMed ID: 33342816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis.
    Phan K; Ng W; Lu VM; McDonald KL; Fairhall J; Reddy R; Wilson P
    World Neurosurg; 2018 Mar; 111():e539-e545. PubMed ID: 29288860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.
    Chen L; Voronovich Z; Clark K; Hands I; Mannas J; Walsh M; Nikiforova MN; Durbin EB; Weiss H; Horbinski C
    Neuro Oncol; 2014 Nov; 16(11):1478-83. PubMed ID: 24860178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of IDH1 mutations in gliomas by high resolution melting analysis, immunohistochemistry and direct DNA sequencing.
    Li J; Zhang H; Wang L; Yang C; Lai H; Zhang W; Chen X; Wang J
    Mol Med Rep; 2015 Sep; 12(3):4376-4381. PubMed ID: 26130305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas.
    Wang Y; Zhang T; Li S; Fan X; Ma J; Wang L; Jiang T
    Eur J Neurol; 2015 Feb; 22(2):348-54. PubMed ID: 25318355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.